4//SEC Filing
Emerald Health Sciences Inc. 4
Accession 0001567619-23-005234
CIK 0001516551other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 2:52 PM ET
Size
17.5 KB
Accession
0001567619-23-005234
Insider Transaction Report
Form 4
Emerald Health Sciences Inc.
10% Owner
Transactions
- Disposition to Issuer
Warrants with Credit Facility of Oct 5, 2018 - T3
2023-02-22−2,500,000→ 0 totalExercise: $0.04From: 2019-03-29Exp: 2024-03-29→ Common Stock (2,500,000 underlying) - Award
Common Stock
2023-02-22$0.02/sh+16,641,486$282,905→ 128,028,737 total - Award
Common Stock
2023-02-22$0.04/sh+41,379,164$1,597,236→ 169,407,901 total - Purchase
Warrants with Credit Facility of Oct 5, 2018
2023-02-22−2,500,000→ 0 totalExercise: $0.04From: 2018-11-01Exp: 2023-11-01→ Common Stock (2,500,000 underlying) - OtherSwap
Warrants
2022-11-10+9,141,486→ 9,141,486 totalExercise: $0.15From: 2023-11-10Exp: 2024-12-30→ Common Stock (9,141,486 underlying) - Disposition to Issuer
Warrants
2023-02-22−9,141,486→ 0 totalExercise: $0.02From: 2023-11-10Exp: 2024-12-30→ Common Stock (9,141,486 underlying) - Disposition to Issuer
Warrants with Credit Facility of Oct 5, 2018 - T2
2023-02-22−2,500,000→ 0 totalExercise: $0.04From: 2019-02-01Exp: 2024-02-01→ Common Stock (2,500,000 underlying)
Footnotes (2)
- [F1]Warrants were acquired pursuant to a merger between Issuer and Emerald Health Therapeutics, Inc. ("Emerald"), whereby Reporting Person's outstanding warrants to purchase Emerald common stock were exchanged for warrants to purchase Issuer common stock.
- [F2]Aggregate exercise price for the warrants was paid through a reduction in the debt Issuer owed to Reporting Person under the Multi Draw Credit Facility.
Documents
Issuer
Skye Bioscience, Inc.
CIK 0001516551
Entity typeother
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001728413
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 2:52 PM ET
- Size
- 17.5 KB